CRP and infection: Therefore, the use of procalcitonin as an infection marker in patients with ARF, particularly when serum creatinine levels exceed 2 mg/dL, remains controversial.6,7 Additionally, both procalcitonin and CRP are partially cleared by renal replacement therapies, further limiting their reliability as infection biomarkers in this patient population.8